Seelos Therapeutics Inc
SEEL
Get informed when a big investor buys or sells
+ FollowMarket Cap$214.97K
Close$
$-1.87
604.2% downside
Current Fair Value
604.2% downsideOvervalued by 604.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $214,970.00 |
|---|---|
| Enterprise Value | $10.08 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-7.73 |
| Beta | 1.94 |
| Outstanding Shares | 864,419 |
Return
| Return on Equity | -14.54% |
|---|---|
| Return on Assets | 171.82% |
| Return on Invested Capital | 106.00% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | 0.05 |
| Price to Sales | 0.19 |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 5 |
| Enterprise Value to EBIT | -0.34 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 1.01 |
| Debt to Equity | -0.36 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Seelos Therapeutics Inc
CEO: Raj Mehra